Genetic variation in the folate metabolic pathway and risk of childhood leukemia.

Blood
Tracy LightfootUnited Kingdom Childhood Cancer Study

Abstract

Studies of childhood leukemia and the potential etiologic role of genetic variation in folate metabolism have produced conflicting findings and have often been based on small numbers. We investigated the association between polymorphisms in key folate metabolism enzymes (MTHFR 677 C>T, MTHFR 1298 A>C, SHMT1 1420 C>T, MTR 2756 A>G, TS 1494del6, and TS 28bp repeat) in 939 cases of childhood acute lymphoblastic leukemia (ALL) and 89 cases of acute myeloid leukemia (AML) recruited into the United Kingdom Childhood Cancer Study. We also examined the maternal genotypes of 752 of these cases. Data from 824 noncancer controls recruited were used for comparison. No evidence of an association with MTHFR 677 was observed for ALL or AML, either in children or their mothers. However, in children an increased risk of ALL (odds ratio [OR] = 1.88; 95% confidence interval [CI], 1.16-3.07; P = .010) and AML (OR = 2.74; 95% CI, 1.07-7.01; P = .036) was observed with the MTR 2756 GG genotype; the association was most pronounced for cases with the MLL translocation (OR = 4.90; 95% CI, 1.30-18.45; P = .019). These data suggest that genetic variation in methionine synthase could mediate risk of childhood leukemia, either via effects on DNA methylatio...Continue Reading

References

Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·B C BlountB N Ames
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·K B GaleM F Greaves
Feb 3, 1999·Annual Review of Genetics·J D Rowley
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·C F SkibolaG Morgan
Nov 7, 1999·Lancet·J L WiemelsM F Greaves
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·J L WiemelsUNKNOWN United Kingdom Childhood Cancer Study investigators
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi MoriMel Greaves
Nov 16, 2002·British Journal of Cancer·L L HjalgrimH Hjalgrim
Jun 27, 2003·American Journal of Hematology·Gunay BaltaAytemiz Gurgey
Feb 24, 2004·American Journal of Epidemiology·Linda Sharp, Julian Little
Jul 9, 2004·Toxicology and Applied Pharmacology·Richard H FinnellThomas H Rosenquist
Aug 18, 2004·Toxicology and Applied Pharmacology·Tracy J Lightfoot, Eve Roman
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Partha M Das, Rakesh Singal
Aug 13, 2005·Journal of Pediatric Hematology/oncology·Elisabete OliveiraMaria João Prata
Dec 21, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tracy J LightfootMartyn T Smith
Feb 2, 2006·International Journal of Cancer. Journal International Du Cancer·Elizabeth MilneBruce K Armstrong
Oct 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tiago Veiga PereiraRendrik França Franco
Jul 12, 2007·Cancer Immunology, Immunotherapy : CII·Malcolm TaylorUNKNOWN UKCCS Investigators
Aug 16, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tracy J LightfootDavid Forman
Sep 6, 2008·American Journal of Obstetrics and Gynecology·Denise L F FurnessGustaaf A Dekker
Aug 15, 2009·Human Molecular Genetics·Josef DavidssonBertil Johansson
Sep 9, 2009·Cancer Epidemiology·Lisa WorrillowTracy J Lightfoot

❮ Previous
Next ❯

Citations

Jul 13, 2011·Cancer Causes & Control : CCC·Catherine MetayerPatricia A Buffler
Sep 4, 2012·Cancer Causes & Control : CCC·Philip J LupoMichael E Scheurer
Dec 15, 2012·International Journal of Hematology·Kevin Y UrayamaShuki Mizutani
Oct 5, 2013·Gene·Fakhira Hassan NazkiBashir Ahmad Ganaie
Oct 5, 2011·Nutrition Reviews·Eric D CiappioJimmy W Crott
Feb 14, 2013·Cancer Epidemiology·Catherine MetayerPatricia A Buffler
Sep 18, 2012·Gene·Izabela ChojnickaRafał Płoski
Jul 17, 2015·Journal of Cancer Research and Clinical Oncology·Songyu CaoZhibin Hu
Aug 3, 2010·Cancer Epidemiology·W Thomas JohnstonEve Roman
Jan 11, 2013·Pediatric Blood & Cancer·Susan E PuumalaLogan G Spector
Feb 13, 2010·British Journal of Haematology·Tracy J LightfootChris F Skibola
Apr 5, 2016·International Journal of Molecular Sciences·Antonio F Hernández, Pablo Menéndez
Apr 11, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Shan-Liang ZhongJian-Hua Zhao
Dec 19, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Madara KreileBaiba Lace
Jun 5, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Song DongJieping Chen
Mar 13, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Su-yi LiMo Yang
Jul 7, 2016·Pharmacogenomics·Juan Eduardo Megías-VericatSalvador F Aliño
Dec 22, 2017·The Indian Journal of Medical Research·Nirmalya Roy MoulikSuraksha Agrawal
Jun 23, 2018·International Journal of Radiation Biology·Melis KarabulutogluChristophe Badie
Sep 18, 2012·American Journal of Botany·Geneviève Dufour-TremblayStéphane Boudreau
Apr 16, 2020·Pediatric Blood & Cancer·Yordan SbirkovVictoria Sarafian
Jun 21, 2011·Molecular Biology Reports·Gustavo Henrique MarucciErika Cristina Pavarino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.